Benadryl and Hypermetabolism - a phase IV clinical study of FDA data

Summary:

Hypermetabolism is reported as a side effect among people who take Benadryl (diphenhydramine hydrochloride), especially for people who are female, 60+ old, also take Zometa, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Hypermetabolism when taking Benadryl. It is created by eHealthMe based on reports of 100,139 people who have side effects when taking Benadryl from the FDA, and is updated regularly.

What is Benadryl?

Benadryl has active ingredients of diphenhydramine hydrochloride. It is often used in allergies. eHealthMe is studying from 104,954 Benadryl users. Check the latest studies of Benadryl.

What is Hypermetabolism?

Hypermetabolism (abnormal increase in the body's basal metabolic rate) is found to be associated with 183 drugs and 189 conditions by eHealthMe. Check the latest studies of Hypermetabolism.

On Jul, 08, 2026

100,139 people reported to have side effects when taking Benadryl.
Among them, 15 people (0.01%) have Hypermetabolism.

Among these 15 people:

What is the gender of people who have Hypermetabolism when taking Benadryl? *

female: 80 %
male: 20 %

What is the age of people who have Hypermetabolism when taking Benadryl? *

What are other drugs people take besides Benadryl? *

Lorazepam: 13 people, 86.67%
Neurontin: 13 people, 86.67%
Aredia: 13 people, 86.67%
Carboplatin: 13 people, 86.67%
Cytoxan: 13 people, 86.67%
Demerol: 13 people, 86.67%
Dexamethasone Sodium Phosphate: 13 people, 86.67%
Faslodex: 13 people, 86.67%
Gemzar: 13 people, 86.67%
Zometa: 13 people, 86.67%

What are other side effects people have besides Hypermetabolism? *

Pain: 15 people, 100.00%
Metastases To Pelvis (cancer spreads to pelvis): 13 people, 86.67%
Osteonecrosis Of Jaw (death of bone of jaw): 13 people, 86.67%
Osteolysis (dissolution of bone): 13 people, 86.67%
Herpes Zoster: 13 people, 86.67%
Emotional Distress: 13 people, 86.67%
Nasal Ulcer (ulcer of nose): 13 people, 86.67%
Essential Hypertension (primary hypertension): 13 people, 86.67%
Eye Allergy: 13 people, 86.67%
Metastases To Spine (cancer spreads to spine): 13 people, 86.67%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 46.67%
Neoplasm Malignant (cancer tumour): 7 people, 46.67%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 13.33%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 13.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Benadryl and have Hypermetabolism?

- Check whether Hypermetabolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benadryl:

Benadryl (104,954 reports)

Browse all side effects of Benadryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypermetabolism:

Hypermetabolism (183 drugs)

Browse all the conditions that are associated with Hypermetabolism:

Hypermetabolism (189 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride (the active ingredients of Benadryl) and Benadryl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.